Diagnostics Industry
Filter News
Found 2,340 articles
-
Asuragen to Present at 2019 European Society of Human Genetics (ESHG) Conference
6/11/2019
Corporate satellite meeting and numerous scientific posters feature new Asuragen products
-
SpeeDx Receives FDA Breakthrough Designation for ResistancePlus® GC
6/11/2019
New diagnostic test enables antibiotic resistance testing and stewardship in gonorrhea treatment
-
MX3 Diagnostics Emerges from Stealth, Announces World’s First Portable, Reliable Saliva-Based Hydration Testing System
6/10/2019
MX3 Diagnostics Inc., a startup that has developed the world’s first real-time saliva-based hydration test, announced the pre-order availability of its flagship portable product, the MX3 Hydration Testing System Pro Version.
-
Help us identify the leading employers in the life science industry! We want to uncover who leads in key areas like diversity, culture, unique benefits and, of course, who are the 2019 Life Sciences Ideal Employers.
-
PromarkerD features at American Diabetes Association 79th Scientific Sessions saying diabetics deserve to know their future kidney disease status
6/7/2019
Proteomics International meeting with US tier 1 national diagnostic groups to expand global roll-out of PromarkerD including EU and Mexico
-
Mérieux NutriSciences and bioMérieux Issue the Results of a Food Safety Survey for the World Food Safety Day
6/7/2019
For this inaugural World Food Safety Day, Mérieux NutriSciences and bioMérieux conducted an international consumer survey1 to better understand consumer perception and behaviors towards food safety in four countries: the United States, China, France and India.
-
Analysis of Newly Expanded Cumulative Cohort Demonstrates that DecisionDx-Melanoma Improves Risk Prediction for Patients with Cutaneous Melanoma
6/6/2019
Poster presentation at 2019 Fall Clinical Dermatology Conference for PAs & NPs
-
Akonni Biosystems Receives FDA 510(k) Clearance of Its TruDiagnosis Multiplex Diagnostic System
6/6/2019
FDA clearance is part of Company's three-part strategy to change the business paradigm for the molecular diagnostic industry
-
As a valued member of our BioSpace community, we are eager to hear more from you and other readers in 2019. We want to know your if you have 'work-life balance' with your job.
-
Information exposed in the hacking includes financial data, Social Security numbers and medical information, Quest said.
-
According to a BioSpace survey, almost 70% of respondents are likely to look for a new job in the 12 months. The question is, why? Of those planning to look for a new job, 54% said they wanted new challenges and 42% said they wanted more rewarding opportunities. How about you? Are you ready to lo...
-
Epigenomics AG to Participate in Raymond James Life Sciences and MedTech Conference in June
6/4/2019
Epigenomics AG announced that company management will be presenting at the Raymond James Life Sciences and MedTech Conference in New York on Tuesday, June 18, 2019, at 1:50 pm / 7:50 pm and invites investors to participate by webcast.
-
Prospective, Multicenter Study of DecisionDx-Melanoma Supports Accuracy and Performance in Prediction of Cutaneous Melanoma Outcomes
6/4/2019
Results from cohort with median follow up of 3.2 years presented at 2019 ASCO Annual Meeting
-
True Health Launches @Home Service to Drive Consumer-Centered Diagnostic Testing
6/4/2019
Mobile Health Assessment is the First National Laboratory Service Available to Consumers in their Home or Office
-
Quidel Announces Private Exchange Transactions - June 4, 2019
6/4/2019
Quidel Corporation, a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced that it has entered into separate, privately negotiated exchange agreements with certain holders of its 3.25% Convertible Senior Notes due 2020.
-
Nanostics Announces Launch of its Clinical Validation Study for ClarityDX Prostate
6/4/2019
Nanostics Inc., a company developing a novel liquid biopsy platform for the early diagnosis of clinically significant prostate cancer, is pleased to announce the start of its key clinical validation study.
-
Asuragen NGS System Streamlines Detection of NSCLC-associated DNA Mutations, Gene Fusions, and RNA Expression Targets in Single Workflow
6/4/2019
The targeted NGS panel enables the detection of 135 RNA and 55 DNA variants associated with non-small cell lung cancer
-
Proteomics International and PromarkerD at BIO 2019 saying 30 million diabetics in US deserve to know their future kidney disease status
6/3/2019
PromarkerD world's leading diagnostic test for diabetic kidney disease says Frost & Sullivan industry report 'Biomarkers Enabling Diabetes and Obesity Management'
-
SQI Diagnostics Announces Stock Option Grant - June 3, 2019
6/3/2019
SQI Diagnostics Inc. announced that effective May 21, 2019, they have granted 3,199,728 stock options as part of a Company-wide long-term incentive plan.
-
Day Zero Diagnostics Launches Whole Genome Sequencing Service That Provides Precise, Reliable Results for Hospital Outbreak Investigations
6/3/2019
Rapid results from epiXact enable hospitals to make quick and confident decisions regarding interventions for patient safety